Plenary Discussion: How can the European market remain competitive on a global stage
17 Sep 2019
This discussion will focus on:
- What happened since the first European approval?
- Are we continuing to produce ATMPs in a cost-effective way?
- Will Brexit bring more complexity in supply chain?
- Investment opportunities in Europe vs. in the US - are we maintaining a competitive advantage for biotechs in Europe?